Literature DB >> 4956901

Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. II. The role of complement components in the increased sensitivity of PNH red cells to immune lysis.

W F Rosse, J V Dacie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 4956901      PMCID： PMC292751          DOI： 10.1172/JCI105389

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  10 in total

1.  STUDIES ON THE TERMINAL STEPS OF IMMUNE HEMOLYSIS. I. INHIBITION BY TRISODIUM ETHYLENEDIAMINETETRAACETATE (EDTA).

Authors:  M M FRANK; H J RAPP; T BORSOS
Journal:  J Immunol       Date:  1964-09       Impact factor: 5.422

2.  CHROMATOGRAPHIC SEPARATION OF THE FIRST COMPONENT OF COMPLEMENT AND ITS ASSAY ON A MOLECULAR BASIS.

Authors:  T BORSOS; H J RAPP
Journal:  J Immunol       Date:  1963-12       Impact factor: 5.422

3.  EFFECTS OF LOW IONIC STRENGTH ON IMMUNE HEMOLYSIS.

Authors:  H J RAPP; T BORSOS
Journal:  J Immunol       Date:  1963-12       Impact factor: 5.422

4.  ACTION OF THE FIRST COMPONENT OF COMPLEMENT. ACTIVITATION OF C'1 TO C'1A IN THE HEMOLYTIC SYSTEM.

Authors:  T BORSOS; H J RAPP; U L WALZ
Journal:  J Immunol       Date:  1964-01       Impact factor: 5.422

5.  STUDIES ON THE TERMINAL STEPS OF IMMUNE HEMOLYSIS. II. RESOLUTION OF THE E TRANSFORMATION REACTION INTO MULTIPLE STEPS.

Authors:  M M FRANK; H J RAPP; T BORSOS
Journal:  J Immunol       Date:  1965-02       Impact factor: 5.422

6.  EXPERIMENTAL PRODUCTION OF COLD AGGLUTININS IN RABBITS.

Authors:  N COSTEA; V YAKULIS; P HELLER
Journal:  Blood       Date:  1965-09       Impact factor: 22.113

7.  THE HEMOLYSIS OF RED CELLS FROM PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA BY PARTIALLY PURIFIED SUB-COMPONENTS OF THE THIRD COMPLEMENT COMPONENT.

Authors:  S YACHNIN
Journal:  J Clin Invest       Date:  1965-09       Impact factor: 14.808

8.  Comparison of the sensitivity to agglutination and haemolysis by a high-titre cold antibody of the erythrocytes of normal subjects and of patients with a variety of blood diseases including paroxysmal nocturnal haemoglobinuria.

Authors:  S M LEWIS; J V DACIE; D TILLS
Journal:  Br J Haematol       Date:  1961-01       Impact factor: 6.998

9.  Hemolysin titration based on fixation of the activated first component of complement: evidence that one molecule of hemolysin suffices to sensitize an erythrocyte.

Authors:  T Borsos; H J Rapp
Journal:  J Immunol       Date:  1965-09       Impact factor: 5.422

10.  Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody.

Authors:  W F Rosse; J V Dacie
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808
  10 in total
  10 in total

1.  Mechanisms of immune lysis of the red cells in hereditary erythroblastic multinuclearity with a positive acidified serum test and paroxysmal nocturnal hemoglobinuria.

Authors:  W F Rosse; G L Logue; J Adams; J H Crookston
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

2.  Paroxysmal nocturnal haemoglobinuria and leukaemia.

Authors: 
Journal:  Br Med J       Date:  1969-08-30

3.  Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria.

Authors:  C J Parker; P J Baker; W F Rosse
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

4.  Detection of complement components on unlysed erythrocytes from acid hemolysis and thrombin test reactions in paroxysmal nocturnal hemoglobinuria.

Authors:  D E Jenkins; W N Christenson; R L Engle
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808

5.  Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody.

Authors:  W F Rosse; J V Dacie
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808

6.  Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.

Authors:  A Nicholson-Weller; J P March; S I Rosenfeld; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

7.  Studies of paroxysmal nocturnal hemoglobinuria erythrocytes: increased lysis and lipid peroxide formation by hydrogen peroxide.

Authors:  C E Mengel; H E Kann; W D Meriwether
Journal:  J Clin Invest       Date:  1967-11       Impact factor: 14.808

8.  Measurement of the third component of complement bound to red blood cells in patients with the cold agglutinin syndrome.

Authors:  G L Logue; W F Rosse; J P Gockerman
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

9.  Evolutionary dynamics of paroxysmal nocturnal hemoglobinuria.

Authors:  Nathaniel Mon Père; Tom Lenaerts; Jorge M Pacheco; David Dingli
Journal:  PLoS Comput Biol       Date:  2018-06-18       Impact factor: 4.475

Review 10.  Immunological Basis of the Endometriosis: The Complement System as a Potential Therapeutic Target.

Authors:  Chiara Agostinis; Andrea Balduit; Alessandro Mangogna; Gabriella Zito; Federico Romano; Giuseppe Ricci; Uday Kishore; Roberta Bulla
Journal:  Front Immunol       Date:  2021-01-11       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.